...
首页> 外文期刊>Microbial drug resistance: MDR : Mechanisms, epidemiology, and disease >Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants.
【24h】

Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants.

机译:结核分枝杆菌过氧化氢酶过氧化物酶(KatG)和耐异烟肼的KatG突变体的三维模型和分子机理。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mycobacterium tuberculosis KatG enzyme functions both as catalase for removing hydrogen peroxide (H(2)O(2)) and as peroxidase for oxidating isoniazid (INH) to active form of anti-tuberculosis drug. Although mutations in M. tuberculosis KatG confer INH resistance in tuberculous patients, structural bases for INH-resistant mutations in the KatG gene remains poorly understood. Here, three M. tuberculosis KatG mutants bearing Arg418--> Gln, Ser315 --> Thr, or Trp321 --> Gly replacement were assessed for changes in catalase-peroxidase activities and possible structure bases relevant to such changes. These three M. tuberculosis KatG mutants exhibited a marked impairment or loss of catalase-peroxidase activities. The possible structural bases for the mutant-induced loss of enzyme activities were then analyzed using a three-dimensional model of M. tuberculosis KatG protein constructed on the basis of the crystal structure of the catalase-peroxidase from Burkholderia pseudomallei. The model suggests that three M. tuberculosis KatG mutants bearing Arg418 --> Gln, Ser315 -->Thr, or Trp321--> Gly replacement affect enzyme activities by different mechanisms, although each of them impacts consequently on a heme-associated structure, the putative oxidative site. Moreover, in addition to the widely accepted substrate-binding site, M. tuberculosis KatG may bear another H(2)O(2) binding site. This H(2)O(2) binding site appears to interact with the catalytic site by a possible electron-transfer chain, a Met255-Tyr229-Trp107 triad conserved in many catalase-peroxidases. The Ser315 --> Thr mutant may have direct effect on the catalytic site by interfering with electron transfer in addition to the previously proposed mechanism of steric constraint.
机译:结核分枝杆菌KatG酶既可以作为过氧化氢酶来去除过氧化氢(H(2)O(2)),也可以作为过氧化物酶来将异烟肼(INH)氧化为抗结核药物的活性形式。尽管结核分枝杆菌KatG中的突变赋予结核病患者INH耐药性,但对KatG基因中INH耐药性突变的结构基础仍知之甚少。在这里,评估了三个携带Arg418-> Gln,Ser315-> Thr或Trp321-> Gly置换的结核分枝杆菌KatG突变体的过氧化氢酶过氧化物酶活性的变化以及与这种变化有关的可能的结构基础。这三个结核分枝杆菌KatG突变体表现出明显的过氧化氢酶过氧化物酶活性受损或丧失。然后使用基于来自伯克霍尔德酵母的过氧化氢酶-过氧化物酶的晶体结构构建的结核分枝杆菌KatG蛋白的三维模型,分析了突变体诱导的酶活性丧失的可能结构基础。该模型表明,携带Arg418-> Gln,Ser315-> Thr或Trp321-> Gly置换的三个结核分枝杆菌KatG突变体通过不同的机制影响酶的活性,尽管它们每个都影响血红素相关的结构,假定的氧化位点。此外,除了广泛接受的底物结合位点,结核分枝杆菌KatG可能带有另一个H(2)O(2)结合位点。此H(2)O(2)结合位点似乎与催化位点通过可能的电子转移链相互作用,Met255-Tyr229-Trp107三联体在许多过氧化氢酶过氧化物酶中均保守。除先前提出的空间位阻机制外,Ser315-> Thr突变体还可能通过干扰电子转移而对催化位点产生直接影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号